The U.S. Department of Veterans Affairs (VA) has partnered with the leaders in precision medicine at Allelica to perform a clinical genomics study aimed at reducing cardiovascular risk in veterans.

Driven Bioinformatics, and Expanding R&D Investments Accelerate Global Pharmacogenomics Market Growth.Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Pharmacogenomics Market Size & Growth ...

Pharmacogenomics (PGx) is a foundational component of precision medicine, yet many laboratories and health systems continue ...

There's more than 20,000 prescription medications available in the U.S., but the Robert J. Dole VA Medical Center has an ace in the hole when it comes to figuring out which ones work best for each ...

In this free webinar, see how DPYD testing can be implemented from guidelines to go-live through practical pharmacogenomics (PGx) reporting and workflow design. The featured speakers will share ...

In 2022, Arizona was one of the first states in the nation to pass legislation (House Bill 2144) requiring Medicaid and commercial insurance plans to cover qualified biomarker tes ...

Anbio Biotechnology (NASDAQ: NNNN) ('Anbio' or the 'Company'), a global diagnostic company in in-vitro diagnostic (IVD) technologies, announced today that its CEO will participate in the upcoming ...

A Malaysian researcher is studying the prospect of prescribing medicine based on a patient's DNA to help them receive safer ...

Mayo Clinic research teams use a multidisciplinary approach to understand and identify factors associated with clinical diagnoses and treatment responses.

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, today announced enhancements to its Whole Genome Sequencing (WGS) test with the ...